A8502 (2023-24 session)
NY State bill
Requires health insurance policies and medicaid to cover biomarker precision medical testing for diagnosis, treatment, or appropriate management of, or ongoing monitoring to guide treatment decisions for, a covered person's disease or condition when the test has recognized efficacy and appropriateness for such purposes.
- Title
- Requires health insurance policies and medicaid to cover biomarker precision medical testing for certain purposes
- Type
- New York State Assembly bill
- Session
- 2023-24 session
- Status
- Signed by Governor
- Latest action date
- 2024-02-07
- Introduced
- 2024-01-04
- Same as
- S8040
- Law section
- Insurance Law
Sponsors
Co-sponsors
Heard in committee
- Insurance NY State Assembly committee
- Rules NY State Assembly committee
- Ways and Means NY State Assembly committee
- Rules NY State Senate committee
Same as
- S8040 (2023-24 session) NY State bill
Substituted for
- S8040 (2023-24 session) NY State bill